Advanced solutions to develop drugs and vaccines for deadly infectious diseases for the betterment of the global population.

Our Mission

Research and Diagnostics



GuardRX is committed to becoming a global leader in the development of life-saving products that can be immediately utilized in order to optimize the response to emergencies of public health concern.



Guard Rx develops diagnostic tests and provides diagnostic services, ensuring a safe work enviroment while protecting remote communities. For more information contact

In The News


Un cas présumé de COVID-19 à la mine Mary River, au Nunavut

Il s’agit d’un employé asymptomatique qui a reçu un résultat positif en arrivant sur le site minier, a fait savoir Baffinland dans un communiqué de presse, jeudi soir. L’employé se trouve actuellement en isolement. L’entreprise indique avoir lancé des procédures de recherches de contacts pour déterminer s’il y a des risques possibles de transmission. Read More.

Guard RX provides thorough COVID-19 testing for Diavik Diamond Mine of RioTinto

Rio Tinto has made arrangements for thorough COVID-19 testing for its employees. The step was taken as a precautionary measure. In order to protect its workers, Rio Tinto will have the facility of COVID-19 testing at Diavik diamond mine in Northwest Territories, Canada. The step was taken as a precautionary measure. One on-site laboratory has been installed at Diavik, […]

GuardRx working to slow COVID-19

  WHEN THE LATE Bob Simon interviewed Gary Kobinger for 60 Minutes in 2015, Kobinger was working principally in a space suit in a special clean room behind bulletproof glass. At the time, he was a top virologist at Canada’s National Microbiology Lab, where he became a key player in the development of the early Ebola treatment ZMapp, as well […]

Field Work in Africa

Field work in Africa will also keep GuardRX researchers busy. Through numerous collaborations, the construction of clinics, and the installation of mobile laboratories, we will assist local communities to diagnose and detect pathogens that are of interest to them. We will also train them to conduct clinical studies on vaccines, ensuring that they use good laboratory practices, so that the accumulated data can be recognized by the main regulatory agencies.